CULTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS FROM WHOLE-BLOOD - EFFECT OF ANTICOAGULANT AND INOCULUM SIZE ON VIRUS GROWTH

被引：11

作者：

BAYLISS, GJ ^{[1
]}

JESSON, WJ ^{[1
]}

MORTIMER, PP ^{[1
]}

MCLEAN, KA ^{[1
]}

EVANS, BA ^{[1
]}

机构：

[1] W LONDON HOSP,DEPT GENITOURINARY MED,LONDON,ENGLAND

来源：

JOURNAL OF MEDICAL VIROLOGY | 1990年 / 31卷 / 02期

关键词：

EDTA anticoagulant; heparin anticoagulant; isolation frequency; T[!sub]4[!/sub] count;

D O I：

10.1002/jmv.1890310215

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Human immunodeficiency virus (HIV) was cultivated directly from whole blood treated with anticoagulant by cocultivation with phytohaemagglutinin‐stimulated cord blood lymphocytes. When heparin was used as the anticoagulant, isolation rates were low (10% to 56%, depending on the patient group); but when EDTA was used, isolation rates were much higher (50% to 100%). Culture of whole blood gave results identical to those of culture of separated peripheral mononuclear cells, and in some cases virus could be isolated from as little as 10 μl of unseparated EDTA anticoagulated blood. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company

引用

页码：161 / 164

页数：4

共 50 条

[21] RECOVERY OF HUMAN-IMMUNODEFICIENCY-VIRUS FROM SERUM
MICHAELIS, BA
LEVY, JA
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (10): : 1327 - 1327
[22] ANTIBODIES TO HEPATITIS DELTA VIRUS AND TO HUMAN-IMMUNODEFICIENCY-VIRUS IN COMMERCIAL BLOOD PRODUCTS
PONZETTO, A
FORZANI, B
HELE, C
AVANZINI, L
LOSTIA, O
CAIOLA, S
LORENZINI, P
LORENZINI, E
VERME, G
HEPATOLOGY, 1986, 6 (05) : 1108 - 1108
[23] PRELIMINARY-REPORT ON AN AUTOMATED SCREENING-TEST FOR DETECTION OF ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN WHOLE-BLOOD
MATSUDA, J
TSUKAMOTO, M
GOHCHI, K
GOTOH, M
SAITOH, N
KAWAMOTO, M
TAKIZAWA, N
KANNO, T
CLINICAL INFECTIOUS DISEASES, 1994, 19 (02) : 327 - 328
[24] TRANSMISSION OF AIDS FROM BLOOD SCREENED NEGATIVE FOR ANTIBODY TO THE HUMAN-IMMUNODEFICIENCY-VIRUS
CONLEY, LJ
HOLMBERG, SD
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (22): : 1499 - 1500
[25] ESTIMATION OF INFECTIOUS POTENTIAL OF BLOOD CONTAINING HUMAN-IMMUNODEFICIENCY-VIRUS
CONNETT, JE
RHAME, FS
THOMAS, J
LE, CT
BIOMETRICAL JOURNAL, 1990, 32 (07) : 781 - 789
[26] COMPARISON OF SALIVA AND BLOOD FOR HUMAN-IMMUNODEFICIENCY-VIRUS PREVALENCE TESTING
MAJOR, CJ
READ, SE
COATES, RA
FRANCIS, A
MCLAUGHLIN, BJ
MILLSON, M
SHEPHERD, F
FANNING, M
CALZAVARA, L
MACFADDEN, D
JOHNSON, JK
OSHAUGHNESSY, MV
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04): : 699 - 702
[27] THE SPECIFICITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 TRANSACTIVATOR IS DIFFERENT FROM THAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
EMERMAN, M
GUYADER, M
MONTAGNIER, L
BALTIMORE, D
MUESING, MA
EMBO JOURNAL, 1987, 6 (12): : 3755 - 3760
[28] ELIMINATION OF HUMAN-IMMUNODEFICIENCY-VIRUS FROM IMMUNOGLOBULIN PREPARATIONS
MORGENTHALER, JJ
LANCET, 1986, 1 (8491): : 1218 - 1218
[29] RECOVERY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS FROM FIBEROPTIC BRONCHOSCOPES
HANSON, PJV
GOR, D
CLARKE, JR
CHADWICK, MV
GAZZARD, B
JEFFRIES, DJ
GAYA, H
COLLINS, JV
THORAX, 1991, 46 (06) : 410 - 412
[30] OUTCOME FROM PERINATAL HUMAN-IMMUNODEFICIENCY-VIRUS ACQUISITION
GUTIERREZ, C
QUINTANA, JM
POCHEVILLE, I
CALLEJA, T
VILLAS, P
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (04) : 336 - 338

← 1 2 3 4 5 →